Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Petranel Ferrao"'
Publikováno v:
Journal of Molecular Graphics and Modelling. 23:139-152
The receptor tyrosine kinase, KIT, displays activating mutations in the kinase domain, which are associated with various cancers. We have used homology modelling based on the crystal structures of the insulin receptor kinase in active and inactive co
Publikováno v:
Leukemia Research. 25:395-405
Drug compartmentalization as well as drug efflux can contribute to drug resistance. We demonstrate the presence of P-gp in intracellular vesicles in certain AML cell lines and show localization of DNR to a similar subcellular compartment(s) that can
Publikováno v:
Leukemia & Lymphoma. 34:451-461
Activating mutations in c-Kit, the receptor for Stem Cell Factor (SCF), have been identified in dysplasias and leukaemias of the mast cell lineage and have been shown to contribute to transformation in model systems. Early myeloid cells also normally
Publikováno v:
Blood. 90:4539-4552
The cDNAs encoding wild type (WT) human receptor tyrosine kinase c-Kit and a constitutively activated mutant, V816Kit, were introduced into granulocyte-macrophage colony-stimulating factor (GM-CSF )-dependent early murine hemopoietic cells, which had
Autor:
Petranel Ferrao, Cliff Meldrum, E. Upjohn, Renate Griffith, George Varigos, Leonie K. Ashman, Ellen M. Byrnes, Rodney J. Scott, Gayle Ross, A. Braue, R. Foster
Publikováno v:
British Journal of Dermatology.
Summary Background The receptor tyrosine kinase c-KIT plays a key role in normal mast cell development. Point mutations in c-KIT have been associated with sporadic or familial mastocytosis. Objectives Two unrelated pairs of apparently identical twins
Publikováno v:
Blood. 102(13)
Elevated expression of multidrug efflux pumps such as P-glycoprotein (Pgp) have been associated with resistance to cytotoxic drugs used in the treatment of leukemias and other cancers. Imatinib mesylate (STI-571 or Gleevec) is a potent inhibitor of t
Publikováno v:
Leukemia research. 27(6)
Mutations of Kit at position D816 have been implicated in mastocytosis, acute myeloid leukaemia and germ cell tumours. Expression of this mutant Kit in cell lines results in factor-independent growth, differentiation and increased survival in vitro a
Autor:
RuJu Chian, Diana Linnekin, Leonie K. Ashman, Alla Danilkovitch-Miagkova, Sonia Young, Lars Rönnstrand, Edward J. Leonard, Petranel Ferrao
Publikováno v:
Blood. 98(5)
Stem cell factor (SCF) binds the receptor tyrosine kinase c-Kit and is critical for normal hematopoiesis. Substitution of valine for aspartic acid 816 (D816V) constitutively actives human c-Kit, and this mutation is found in patients with mastocytosi
Publikováno v:
Leukemia Research. 25:827
Autor:
Edward J. Leonard, A. Danilkovitch-Miagkova, Diana Linnekin, R. Chian, Lars Rönnstrand, S. Young, Petranel Ferrao, Leonie K. Ashman
Publikováno v:
Experimental Hematology. 28:1491
C-Kit is a receptor tyrosine kinase that binds stem cell factor. Substitution of valine for aspartic acid 816 (V816) constitutively activates human c-Kit and this mutation is found in patients with mastocytosis, leukemia and germ cells tumors. Transd